Walleye Capital’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-8,476	Closed	-$203K	–	4316
2025 Q4	$226K	Buy	+8,476	New	+$203K	﹤0.01%	3475
2025 Q3	–	Sell	-87,788	Closed	-$2.08M	–	4403
2025 Q2	$1.89M	Buy	87,788 +35,826	+69%	+$666K	0.02%	1558
2025 Q1	$863K	Sell	51,962 -126,045	-71%	-$2.29M	0.01%	2095
2024 Q4	$3.27M	Buy	178,007 +137,201	+336%	+$2.21M	0.03%	1367
2024 Q3	$628K	Sell	40,806 -63,024	-61%	-$1.05M	0.01%	3084
2024 Q2	$1.69M	Buy	103,830 +64,630	+165%	+$1.04M	0.02%	2270
2024 Q1	$725K	Sell	39,200 -203,505	-84%	-$5.04M	0.01%	2884
2023 Q4	$7.6M	Buy	242,705 +144,104	+146%	+$3.44M	0.11%	836
2023 Q3	$2.05M	Buy	98,601 +74,850	+315%	+$2.03M	0.03%	1718
2023 Q2	$569K	Sell	23,751 -395,092	-94%	-$8.78M	0.01%	2335
2023 Q1	$7.88M	Buy	418,843 +290,923	+227%	+$5.54M	0.16%	194
2022 Q4	$2.04M	Sell	127,920 -81,609	-39%	-$1.28M	0.04%	568
2022 Q3	$3.43M	Sell	209,529 -25,998	-11%	-$421K	0.08%	320
2022 Q2	$3.32M	Buy	235,527 +212,185	+909%	+$3.96M	0.1%	245
2022 Q1	$565K	Sell	23,342 -41,433	-64%	-$1M	0.02%	945
2021 Q4	$1.51M	Sell	64,775 -53,501	-45%	-$1.08M	0.05%	405
2021 Q3	$1.97K	Buy	118,276 +99,276	+523%	+$1.91M	0.06%	231
2021 Q2	$463	Buy	+19,000	New	+$429K	0.02%	776
2020 Q1	–	Sell	-830	Closed	-$36K	–	845
2019 Q4	$36K	Sell	830 -7,043	-89%	-$306K	0.01%	1549
2019 Q3	$283K	Buy	+7,873	New	+$239K	0.19%	1004
2019 Q2	–	Hold	0	–	–	–	1684